Comparison Chart Fate Therapeutics, Inc.

Stocks

FATE

US31189P1021

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
2.410 ^USD	-4.37%		-13.31%	+145.27%

07-09	Fate Therapeutics Shares Rise After FDA Clears Investigational New Drug Application for FT839	MT
07-09	Fate Therapeutics Receives FDA Clearance Of Investigational New Drug Application For FT839 Product Candidate	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	FATE THERAPEUTICS, INC.	Bio Therapeutic Drugs	-4.37%	-13.31%	+145.27%	+92.80%	-97.20%	281M